K.I. Pritchard - Concepedia

Author

K.I. Pritchard

Also Known As

K I Pritchard, K Pritchard, K. I. Pritchard, K. Pritchard, K.I. Pritchard, Kathy I Pritchard, Kathy I. Pritchard, Kathy Pritchard

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Sunnybrook Health Science Centre University of Toronto McMaster University Women's College Hospital Queen's University

About

K.I. Pritchard is an author at Sunnybrook Health Science Centre specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	752
2	Health Sciences	3	3	376
3	Endocrinology	2	2	63
4	Nursing	1	1	27
5	Geriatrics	1	1	27

K.I. Pritchard

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
NCIC-CTG MA.20: An intergroup trial of regional nodal irradiation in early breast cancer. Timothy J. Whelan, Ivo A. Olivotto, Ida Ackerman, Journal of Clinical Oncology Surgical OncologyBreast OncologyLba1003 BackgroundSurgeryRadiation Medicine	2011	241
Effect of Metformin vs Placebo on and Metabolic Factors in NCIC CTG MA.32 Pamela J. Goodwin, Wendy R. Parulekar, Karen A. Gelmon, JNCI Journal of the National Cancer Institute	2015	129
Baseline staging tests in primary breast cancer: a practice guideline. Robert E. Myers, Mary Johnston, K.I. Pritchard, PubMed	2001	129
NCIC CTG MA.20: An intergroup trial of regional nodal irradiation in early breast cancer. Timothy J. Whelan, I. Olivotto, I. Ackerman, Journal of Clinical Oncology Surgical OncologyBreast OncologyCancer ManagementPathologyAnnual Meeting Proceedings	2011	119
First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2251 patients Ian E. Smith, Jean‐Yves Pierga, Laura Biganzoli, Annals of Oncology Metastatic Breast CancerBreast OncologyFirst-line BevacizumabMedicinePathology	2010	103
Phase III Randomized Trial of Droloxifene and Tamoxifen As First-Line Endocrine Treatment of ER/PgR-Positive Advanced Breast Cancer Aman U. Buzdar, Daniel F. Hayes, A. El-Khoudary, Breast Cancer Research and Treatment Endocrine OncologyBreast OncologyOncologyPharmacologyClinical Trials	2002	66
Abstract S4-07: Effects of bisphosphonate treatment on recurrence and cause-specific mortality in women with early breast cancer: A meta-analysis of individual patient data from randomised trials RE Coleman, Michael Gnant, AlexanderH.G. Paterson, Cancer Research Breast OncologyIndividual Patient DataDistant RecurrenceGynecologyBisphosphonate Treatment	2013	62
Estrogen and progesterone receptor content of primary and secondary breast carcinoma: Influence of time and treatment B.G. Mobbs, Edward B. Fish, K.I. Pritchard, European Journal of Cancer and Clinical Oncology Breast OncologyMedicineHormonal ReceptorSecondary Breast CarcinomaGynecology	1987	46
Impact of Stopping Trastuzumab in Early Breast Cancer: A Population-Based Study in Ontario, Canada Moira Rushton, Isac Lima, Meltem Tuna, JNCI Journal of the National Cancer Institute	2020	30
Phase II study of lonidamine in patients with metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group Study. Pierre R. Band, J. Maroun, K.I. Pritchard, PubMed National Cancer InstituteMetastatic Breast CancerBreast OncologyMedicineCancer Management	1986	27

Page 1